How to actually start peptides — the framework that prevents most regret

The question this piece answers is not whether peptides are worth pursuing. That's already behind you. The question is: given that you've decided to investigate this seriously, what is the correct order of operations, and what does it look like when it's done right versus when it's done in the way that tends to produce regret?

The framework has six components, and the sequence matters more than any individual step.

The first is baseline evaluation — not a perfunctory ten-minute call that ends with a prescription, but a real clinical intake with a prescribing clinician who is actually evaluating you rather than processing you. This distinction is not subtle in practice. A clinician who is genuinely evaluating you will ask about your history, your goals, your current symptom picture, your medications and supplements, your sleep, your metabolic health, and your stress load. They will want labs before they recommend anything. They will tell you if they think something isn't the right fit for your situation. A clinician who is processing you will ask what you want and how to route the prescription. You can usually tell the difference within the first few minutes of a consultation.

The labs you want before starting are not optional context — they are the foundation for everything that follows. A complete blood count gives you your baseline immune and hematologic state. A comprehensive metabolic panel shows kidney function, liver function, and electrolyte balance — essential baselines for any compound that may place demands on those systems. HbA1c and fasting glucose tell you where your insulin sensitivity actually sits, which is critical context before pursuing anything on the GH axis or any GLP-1 adjacent compound. A lipid panel. A thyroid panel that includes TSH, free T3, and free T4 — not just TSH — because thyroid dysfunction is common, frequently missed with TSH alone, and produces symptoms that overlap with many of the conditions peptides are considered for. Sex hormones: total and free testosterone, SHBG, and estradiol. DHEA-S. IGF-1 if you're considering anything GH-related. Morning cortisol. The foundational micronutrients — 25-OH vitamin D, ferritin, B12, folate, magnesium — because deficiencies here are remarkably common and can both mimic the symptoms you're trying to address and limit the response to any peptide protocol. Inflammatory markers, particularly hsCRP. This is not an extravagant list. It is the minimum responsible picture of where you're starting.

The second component is defining your actual goal in terms that are measurable rather than aspirational. "Improve recovery" is not a goal you can evaluate. "Reduce the number of days of post-workout soreness that limits training, measured consistently over the next twelve weeks" is. "Better sleep" becomes "wake fewer than twice per night and reduce morning fatigue score on a simple 1-10 daily log." The reason this matters is not pedantic. If you don't define what you're measuring before you start, you can't evaluate whether anything is working, and you become entirely dependent on subjective impression, which is unreliable over months and across variables. The goal-setting conversation with your clinician should result in specific, trackable outcomes, not a general sense of optimism.

The third component is single-variable discipline. This is where most people who are enthusiastic about the space go wrong early. The reading has exposed you to stacks, protocols, combinations, and synergistic compounds, and the temptation is to start several things at once because you've waited long enough and you want to give this the best chance. The problem is that you cannot attribute effects — good or bad — when multiple variables change simultaneously. If you start three peptides in the same week and feel meaningfully better, you don't know which one matters. If you develop a side effect, you don't know which compound is responsible. Start one thing. Give it the time required for that specific compound to demonstrate an effect. Then, if your clinician agrees and your monitoring picture supports it, you can consider adding something else with full awareness of what the baseline looked like.

The fourth component is realistic timelines. This deserves its own honest treatment. The marketing language around peptides tends toward the dramatic and the fast. Biological systems don't work on marketing timelines. Depending on what you're working with and what you're measuring, meaningful effects may require four to sixteen weeks of consistent use. Some compounds that act on the GH axis or on tissue repair operate on the slow timescales of tissue remodeling and hormonal recalibration. Expecting dramatic change in two weeks and discontinuing at week three because it hasn't arrived is probably the most common way people fail with protocols that might have worked for them. Your clinician should give you a specific, honest timeline for whatever you're starting — not an optimistic one, not a range so wide it's meaningless, but a reasonable expectation based on what the compound does and how it does it.

The fifth component is a monitoring plan. This means pre-specified follow-up labs — not labs you'll think about ordering if something seems off, but labs scheduled at defined intervals. For most protocols, a follow-up panel at weeks six to eight, and again at three to four months, is a reasonable minimum. It also means a symptom tracking system — something as simple as a daily note with standardized entries is enough — so you have actual data to bring to follow-up appointments rather than a vague sense of things over time. It means knowing what side effects are expected and mild versus what side effects warrant a call to your clinician before the scheduled follow-up. Injection site reactions that are transient and mild are different from symptoms that are worsening or systemic. Know the difference before you start, not after.

The sixth component is exit conditions. This is the one people most reliably skip, and it's the one that prevents a lot of the low-grade regret where a protocol that isn't working keeps continuing because there's no pre-specified criterion for stopping. Before you start, you and your clinician should agree on the conditions under which you would stop or significantly change the protocol. These might include: a specific side effect crossing a threshold, a specific lab marker moving in a direction that concerns you, a defined trial period during which the measurable goal hasn't moved, a cost-benefit shift where what you're spending is no longer justified by what you're getting, or a new medical situation that changes the picture. Having these defined before you start is different from defining them as you go, because hindsight introduces motivated reasoning — you've invested time and money, and there's a pull toward continuing regardless.

What makes this framework work is not the individual steps. It's the relationship with a clinician who is willing to actually do this with you — who wants your baseline labs, who will help you define measurable goals, who will read your follow-up data seriously, and who has the clinical judgment to tell you if something should change. The space between a thorough, structured peptide evaluation and a subscription that ships you a vial with minimal oversight is wider than it looks from the outside. The approach you take to finding a clinician relationship — one characterized by genuine evaluation, honest timelines, and follow-up accountability — is probably the highest-leverage decision you make in this entire process. Everything else follows from whether that relationship is real.

Most regret in this space comes from starting without a baseline, starting multiple things at once, discontinuing too early or too late because there was no agreed-upon timeline, and having no way to evaluate what actually happened because the goal was never made measurable. The framework here doesn't eliminate uncertainty — there's real uncertainty in this space that no framework resolves — but it creates the conditions where you can actually learn from your own experience rather than just accumulating it.